Johnson & Johnson JNJ:NYSE

RT Quote | Last NYSE, VOL From CTA | USD

Last | 12:36 PM EDT

150.17

+1.05 (+0.70%)

Volume

3,090,929

52 week range

143.13 - 175.97

Open149.86
Day High150.21
Day Low148.20
Prev Close149.12
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24

Key Stats

Market Cap361.877B
Shares Out2.41B
10 Day Average Volume8.88M
Dividend4.96
Dividend Yield3.30%
Beta0.54
YTD % Change-4.3

KEY STATS

Open149.86
Day High150.21
Day Low148.20
Prev Close149.12
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24
Market Cap361.877B
Shares Out2.41B
10 Day Average Volume8.88M
Dividend4.96
Dividend Yield3.30%
Beta0.54
YTD % Change-4.3

RATIOS/PROFITABILITY

EPS (TTM)7.55
P/E (TTM)19.89
Fwd P/E (NTM)14.20
EBITDA (TTM)29.873B
ROE (TTM)18.31%
Revenue (TTM)81.796B
Gross Margin (TTM)70.22%
Net Margin (TTM)22.92%
Debt To Equity (MRQ)42.65%

EVENTS

Earnings Date07/17/2024(est)
Ex Div Date05/20/2024
Div Amount1.24
Split Date-
Split Factor-

Latest On Johnson & Johnson

Why this is perfect time to buy health-care stocks, one financial advisor says32 Min AgoCNBC.com
Ford surges on Tesla's EV price cuts as legacy automaker falls back on its roots22 Hours AgoCNBC.com
Cramer’s Mad Dash: Johnson & JohnsonApril 19, 2024CNBC.com
Jim Cramer's top 10 things to watch in the stock market FridayApril 19, 2024CNBC.com
What stands in the way of stocks breaking free of the volatility we've been seeingApril 16, 2024CNBC.com

Content From Our Affiliates

Stryker added to ‘Tactical Outperform’ list at Evercore ISIApril 22, 2024TipRanks
Johnson & Johnson (NYSE:JNJ) Notches Up After Talc WinApril 19, 2024TipRanks
Johnson & Johnson upgraded to Buy at HSBC with shares at three year lowsApril 18, 2024TipRanks
Johnson & Johnson upgraded to Buy from Hold at HSBCApril 18, 2024TipRanks
Hold Rating on Johnson & Johnson Amidst Growth, Competition, and Legal ChallengesApril 18, 2024TipRanks

Profile

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...

Joaquin Duato

Chairman of the Board, Chief Executive Officer

Joseph Wolk

Chief Financial Officer, Executive Vice President

Tim Schmid

Executive Vice President, Worldwide Chairman of MedTech

Elizabeth Forminard

Executive Vice President, General Counsel

John Reed M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

Address

One Johnson & Johnson Plaza

New Brunswick, NJ

08933

United States

https://www.jnj.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	127.15	+0.21	+0.17%
ABBV AbbVie Inc	170.20	+2.31	+1.38%
RHHBY Roche Holding AG	31.32	+0.41	+1.31%
AZN AstraZeneca PLC	70.77	+0.64	+0.91%
NVS Novartis AG	97.59	+2.47	+2.60%